Press Releases

Vivici has been awarded EUR 12.5 million through the EIC Accelerator Program. The funding validates Vivici’s technology and commercial progress while supporting further innovation in sustainable dairy proteins.

Vivici has launched Vivitein™ LF in the US, unlocking commercial access to lactoferrin (often called “pink gold”) through precision fermentation. The high-purity, multi-functional protein ingredient has achieved self-affirmed GRAS status and enables nutrition innovators to develop next-generation products targeting gut health, performance recovery, and sustained vitality. Vivici will showcase Vivitein™ LF and its broader Vivitein™ portfolio at Expo West 2026 in Anaheim (Booth #3894).

Vivici showcases Protein Shots, Protein Soda, and Ready to Mix at SupplySide Global 2025. Visit booth #2077 in Las Vegas.

Introducing Vivitein™ BLG shots at Newtopia Now 2025! These innovative shots are all about redefining compact protein, offering portable, high-quality, vegan-friendly nutrition in just 100ml.

Precision-fermented dairy protein ingredient sustainably delivers breakthrough functional and nutritional benefits. Ingredients startup showcase new ViviteinTM protein platform at Expo West 2025 in Anaheim. Breakthrough ingredient enables a wide range of product innovations in the growing active nutrition category.

Ingredients startup advances on its path to full commercialisation. New investors include Pensioenfonds ABP, Invest-NL, and InnovationQuarter. Startup to launch its second dairy protein from precision fermentation in H2 2025.